Transcode Therapeutics, Inc. (RNAZ) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $162.40M | +2126.3% |
| 2024 | $7.29M | +41.1% |
| 2023 | $5.17M | -31.9% |
| 2022 | $7.59M | -66.9% |
| 2021 | $22.94M | +2073.5% |
| 2020 | $1.06M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $162.40M | +2126.3% |
| 2024 | $7.29M | +41.1% |
| 2023 | $5.17M | -31.9% |
| 2022 | $7.59M | -66.9% |
| 2021 | $22.94M | +2073.5% |
| 2020 | $1.06M | — |